DBV Technologies logo

Senior Director, U.S. Medical Affairs Operations

DBV Technologies

Warren, NJHybridPosted 35 days ago$250,000 - $300,000/year
Full TimeDirector & AboveMedical AffairsBiotechnology
Original posting ↗

Summary

DBV is preparing for the anticipated 2027 U.S. launch of Viaskin and is converting a clinical-development Medical Affairs organization into a launch-ready one. The Senior Director, U.S. Medical Affairs Operations owns the operational infrastructure of U.S. Medical Affairs, turning medical strategy into an executable, funded, compliant and measurable plan and ensuring Medical Affairs is prepared and on time at cross-functional launch readiness governance.

Job description

Key Responsibilities

  • Build and own the U.S. Medical Affairs strategic/tactical plan (1H/2H), translating medical strategy into prioritized projects with owners, milestones, budgets and KPIs.
  • Run the Medical Affairs planning cadence and maintain a single integrated view of all MA workstreams.
  • Design and maintain the Medical Affairs dashboard and project-tracking mechanism; surface risks, slippage and resource conflicts early.
  • Serve as Medical Affairs' operational lead for the cross-functional Launch Readiness Review (LRR).
  • Partner with Commercial, Market Access, Regulatory, Pharmacovigilance and Compliance to integrate MA deliverables into the launch plan and critical path.
  • Map and operationalize the U.S. advisory board plan (2026-2027), including needs assessment, compliant participant selection, FMV contracting, logistics, documentation and insights capture.
  • Oversee congress planning and medical meeting operations in coordination with Medical Communications and Field Medical.
  • Stand up the compliant end-to-end process for medical education grants and IIS, including policy/SOP, review-committee charter, intake and review criteria, contracting, milestone and payment tracking, and close-out.
  • Chair or coordinate the Grants/IIS review committee with Legal, Compliance and Finance; maintain the audit trail and reporting.
  • Triage all Medical Affairs contracting through operations and own vendor selection, onboarding, performance management and renewal.
  • Own the U.S. Medical Affairs budget, including itemized spend plan, monthly accruals, reforecasts and long-range plan input in partnership with FP&A.
  • Deliver budget-to-forecast variance reporting and spend transparency to the Head of Global Medical Affairs and the CFO organization.
  • Capture and report all transfers of value (TOV) under the Physician Payments Sunshine Act / Open Payments and applicable state laws.
  • Ensure MA operations adhere to PhRMA Code, AKS/FMV requirements, ACCME standards, GCP requirements for IIS, and DBV policies; ensure inspection- and audit-readiness.
  • Define the template, systems and cadence for capturing and collating field medical metrics and medical insights into actionable reporting.
  • Partner with Field Medical leadership and IT on CRM/insights tooling and data integrity.
  • Design and build the U.S. MA Operations team through launch; hire, develop and manage direct reports; set performance objectives aligned to the launch plan.
  • Establish scalable ways of working, systems and SOPs that allow Medical Affairs to grow from pre-launch to a full commercial-year operating model.

Qualifications

  • Bachelor's degree in life sciences, business, or related field; advanced degree (MBA, MS, PharmD, PhD) preferred.
  • 12+ years of progressive experience in the biopharmaceutical industry, including 7+ years in Medical Affairs operations or closely adjacent roles.
  • Direct experience operationalizing Medical Affairs through at least one U.S. product launch.
  • Demonstrated ownership of grants/IME and IIS programs, HCP and vendor contracting, and Medical Affairs budget management.
  • Working knowledge of U.S. healthcare compliance frameworks: PhRMA Code, Anti-Kickback Statute and FMV principles, Sunshine Act / Open Payments, ACCME standards, and GCP requirements for investigator-sponsored research.
  • Proven ability to design dashboards, KPIs and reporting; strong financial and analytical fluency (Excel; planning, CRM/insights and contract-management systems).
  • Experience hiring, developing and leading a team, and influencing without authority across a matrixed, cross-functional launch organization.

Preferred

  • Experience in allergy/immunology, pediatrics, or a specialty launch with a significant field medical footprint.
  • Experience in a dual-listed or non-U.S.-headquartered company; comfort partnering with a European HQ.
  • Prior exposure to BLA-stage organizations and inspection-readiness expectations.
  • Project management certification (PMP or equivalent) or formal operational excellence training.

Requirements

  • Bachelor's degree in life sciences, business, or related field
  • 12+ years of progressive experience in the biopharmaceutical industry
  • 7+ years in Medical Affairs operations or closely adjacent roles
  • Direct experience operationalizing Medical Affairs through at least one U.S. product launch
  • Demonstrated ownership of grants/IME and IIS programs, HCP and vendor contracting, and Medical Affairs budget management
  • Working knowledge of PhRMA Code, Anti-Kickback Statute and FMV principles, Sunshine Act / Open Payments, ACCME standards, and GCP requirements for investigator-sponsored research
  • Proven ability to design dashboards, KPIs and reporting
  • Strong financial and analytical fluency (Excel; planning, CRM/insights and contract-management systems)
  • Experience hiring, developing and leading a team
  • Influencing without authority across a matrixed, cross-functional launch organization

Benefits

  • Medical, Dental & Vision
  • 401(k) Matching
  • Paid Time Off

Company overview

DBV Technologies is a global clinical-stage biopharmaceutical company pioneering epicutaneous immunotherapy (EPIT) through its innovative Viaskin™ patch technology platform. Founded by pediatricians in 2002, the company is dedicated to developing safe and effective treatments for food allergies and immunologic diseases with significant unmet medical needs. DBV's core technology involves delivering biologically active compounds through intact skin to re-educate the immune system, offering a non-invasive alternative to traditional allergy treatments. The company's primary focus is on developing the Viaskin peanut patch for pediatric patients with peanut allergy, with ongoing Phase 3 clinical trials across different age groups. Headquartered in Châtillon, France, with operations in Warren, New Jersey, DBV maintains a global presence and is publicly traded on Euronext Paris and Nasdaq. The company's pipeline also includes programs for cow's milk allergy, eosinophilic esophagitis, autoimmune disorders, and vaccine applications, demonstrating the broad potential of its patch-based immunotherapy platform.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.